Literature DB >> 16786906

Sodium and water retention in heart failure and diuretic therapy: basic mechanisms.

Domenic A Sica1.   

Abstract

The pathophysiology of sodium and water retention in heart failure is characterized by a complex interplay of hemodynamic and neurohumoral factors. Relative arterial underfilling is an important signal that triggers heart failure-related sodium and water retention. The response to perceived arterial underfilling is modulated by the level of neurohormonal activation, the degree of renal vasoconstriction, and the extent to which renal perfusion pressure is reduced. Sodium retention can also be exceeded by water retention, with the result being dilutional hyponatremia. Sodium and water retention in heart failure also function to dampen the natriuretic response to diuretic therapy. The attenuated response to diuretics in heart failure is both disease-specific and separately influenced by the rate and extent of diuretic absorption, the rapidity of diuretic tubular delivery, and diuretic-related hypertrophic structural changes that surface in the distal tubule.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16786906     DOI: 10.3949/ccjm.73.suppl_2.s2

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  14 in total

1.  Acetazolamide as a potent chloride-regaining diuretic: short- and long-term effects, and its pharmacologic role under the 'chloride theory' for heart failure pathophysiology.

Authors:  Hajime Kataoka
Journal:  Heart Vessels       Date:  2019-05-21       Impact factor: 2.037

2.  Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients With Acute Heart Failure, Congestion, and Worsening Renal Function.

Authors:  Takeshi Kitai; Justin L Grodin; Yong-Hyun Kim; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2017-02       Impact factor: 8.790

3.  Importance of Abnormal Chloride Homeostasis in Stable Chronic Heart Failure.

Authors:  Justin L Grodin; Frederik H Verbrugge; Stephen G Ellis; Wilfried Mullens; Jeffrey M Testani; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

4.  Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF).

Authors:  Justin L Grodin; Jie-Lena Sun; Kevin J Anstrom; Horng H Chen; Randall C Starling; Jeffrey M Testani; W H Wilson Tang
Journal:  Am J Cardiol       Date:  2016-09-30       Impact factor: 2.778

Review 5.  Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options.

Authors:  Geoffrey T Jao; Jun R Chiong
Journal:  Clin Cardiol       Date:  2010-11       Impact factor: 2.882

6.  Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction.

Authors:  Margaret S Kim; Tomoko S Kato; Maryjane Farr; Christina Wu; Raymond C Givens; Ellias Collado; Donna M Mancini; P Christian Schulze
Journal:  J Am Coll Cardiol       Date:  2013-04-03       Impact factor: 24.094

7.  Diuretics in heart failure: a critical appraisal of efficacy and tolerability.

Authors:  Anita D Szady; James A Hill
Journal:  Drugs       Date:  2009       Impact factor: 9.546

8.  Hyponatremia and congestive heart failure: a marker of increased mortality and a target for therapy.

Authors:  Adam Romanovsky; Sean Bagshaw; Mitchell H Rosner
Journal:  Int J Nephrol       Date:  2011-04-18

9.  Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients.

Authors:  Savina Nodari; Geoffrey T Jao; Jun R Chiong
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-05-10

10.  Water and sodium regulation in heart failure.

Authors:  Eun Hui Bae; Seong Kwon Ma
Journal:  Electrolyte Blood Press       Date:  2009-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.